Gluconeogenesis

USMLE Step 1 trap: Incorrectly assigns gluconeogenesis capability to skeletal muscle, which lacks glucose-6-phosphatase. Skeletal muscle lacks glucose-6-phosphatase and cannot release free glucose; only liver and kidney cortex perform gluconeogenesis for blood glucose maintenance.

Gluconeogenesis is the synthesis of glucose from non-carbohydrate precursors — it's how your body maintains blood glucose during fasting when glycogen runs out. The key concept is that it's not just reverse glycolysis: three glycolytic steps are irreversible, so gluconeogenesis uses four unique bypass enzymes to get around them. USMLE Step 1 tests this topic heavily because it connects fasting physiology, enzyme compartmentalization, and metabolic precursors all in one pathway. Expect vignettes about fasting states, alcoholism (which depletes NAD+ and oxaloacetate), or enzyme deficiencies presenting with hypoglycemia.

The exam probes this from multiple angles. Pure recall questions ask which enzymes are unique to gluconeogenesis. Application questions give you a fasting patient or a substrate (like odd-chain fatty acids) and ask whether gluconeogenesis can proceed. Passage-based questions might describe an enzyme defect and ask where the block is and what accumulates. What trips up most students is assuming gluconeogenesis is just glycolysis run backward — it isn't, and the four bypass enzymes are the entire point.

The two biggest traps: (1) thinking muscle can do gluconeogenesis because it stores glycogen and has the enzymes — it can't release free glucose because it lacks glucose-6-phosphatase; and (2) thinking fatty acids are gluconeogenic because fat is the main fasting fuel — even-chain fatty acids feed acetyl-CoA into the TCA cycle but cannot generate net oxaloacetate, so they cannot be converted to glucose. These are classic USMLE Step 1 wrong-answer traps written to exploit exactly these intuitions.

From real student decks

96%have cards covering this topic

71%have mature cards

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake

Wrong: Skeletal muscle can perform gluconeogenesis to release glucose into the blood during fasting.

Right: Skeletal muscle lacks glucose-6-phosphatase and cannot release free glucose; only liver and kidney cortex perform gluconeogenesis for blood glucose maintenance.

Skeletal muscle has most of the gluconeogenic machinery but critically lacks glucose-6-phosphatase, the enzyme that cleaves the phosphate group to release free glucose into the blood. Without it, any glucose-6-phosphate made in muscle stays trapped and gets used locally — it cannot exit the cell as free glucose. This is why muscle glycogen serves as an internal fuel reserve for muscle only, while the liver and kidney cortex are the tissues responsible for maintaining blood glucose.

Common mistake

Wrong: Fatty acids can serve as gluconeogenic precursors because fat is the primary fasting fuel.

Right: Even-chain fatty acids cannot be used for gluconeogenesis because acetyl-CoA cannot be converted to net oxaloacetate; only odd-chain fatty acids (via propionyl-CoA) contribute.

Even-chain fatty acids are broken down entirely into acetyl-CoA, which enters the TCA cycle but cannot generate net new oxaloacetate — every turn of the TCA cycle that uses acetyl-CoA also consumes oxaloacetate, so there's no net gain. To make glucose, you need a compound that can produce net oxaloacetate (or another gluconeogenic intermediate), and acetyl-CoA alone cannot do that. Odd-chain fatty acids are the exception because their terminal three carbons yield propionyl-CoA, which is converted to succinyl-CoA and then to oxaloacetate, providing a small but real gluconeogenic contribution.

Common mistake

Gap: Missing the subcellular compartments of the four gluconeogenesis bypass enzymes

The four gluconeogenesis bypass enzymes span two compartments: pyruvate carboxylase (mitochondria) and PEPCK, fructose-1,6-bisphosphatase, and glucose-6-phosphatase (cytosol/ER) — compartmentalization is high-yield.

Pyruvate carboxylase works in the mitochondria, converting pyruvate to oxaloacetate — this is why oxaloacetate must be converted to malate or aspartate to cross the inner mitochondrial membrane before gluconeogenesis can continue in the cytosol. PEPCK then converts oxaloacetate to PEP in the cytosol (the predominant location in humans). Fructose-1,6-bisphosphatase acts in the cytosol, and glucose-6-phosphatase is embedded in the ER membrane with its active site facing the ER lumen. Getting this compartmentalization right is essential for questions about transport defects or subcellular localization.

Guided session

Stuck on this? An AI tutor that probes your understanding and catches where your reasoning breaks.

Start a session →

Free Deck audit

Already run Anki? See if your deck covers this topic.

Upload your deck →

What the exam tests

Know which tissues perform gluconeogenesis (liver and kidney cortex) and why skeletal muscle cannot contribute glucose to the blood even though it has many of the same enzymes — the answer is the absence of glucose-6-phosphatase.
Know the four bypass enzymes that replace irreversible glycolytic steps: pyruvate carboxylase, PEPCK, fructose-1,6-bisphosphatase, and glucose-6-phosphatase — and know where each one lives inside the cell (mitochondria vs. cytosol vs. ER membrane).
Know which molecules are valid gluconeogenic precursors (lactate, alanine, glutamine, glycerol, oxaloacetate, odd-chain fatty acids via propionyl-CoA) and which are not (even-chain fatty acids, ketone bodies, pure acetyl-CoA sources) — and be able to explain mechanistically why each cannot contribute net glucose.

Can you avoid these mistakes?

A patient with a genetic deficiency of glucose-6-phosphatase presents with fasting hypoglycemia and hepatomegaly. Which step of gluconeogenesis is blocked, and why does glucose-6-phosphate accumulate in the liver instead of being released as free glucose?

During prolonged fasting, a researcher measures gluconeogenesis rates in liver, skeletal muscle, and kidney cortex. Which tissues show net glucose output into the bloodstream, and what single enzyme explains why skeletal muscle does not?

A biochemistry question states that a patient is oxidizing fatty acids at a high rate during fasting. Can this process directly support gluconeogenesis? Explain your answer in terms of acetyl-CoA and oxaloacetate, and describe under what circumstances fatty acid oxidation CAN contribute to gluconeogenesis.

List the four gluconeogenesis bypass enzymes in order from pyruvate to glucose. For each one, state whether it acts in the mitochondria, cytosol, or ER membrane. Which one requires biotin as a cofactor, and what does that tell you about its mechanism?

Gluconeogenesis

Common misconceptions

What the exam tests

Can you avoid these mistakes?

Related topics